For example, in mice with prostate-specific deletion of both PTEN and TP53, prostate tumors develop much earlier than in PTEN knock-outs, which is due to the absence of TP53-induced cellular senescence [20]. This evidence concerns the gene TP53 and prostate neoplasm.